These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 1823910)

  • 21. Antiviral drug susceptibility of human herpesvirus 8.
    Neyts J; De Clercq E
    Antimicrob Agents Chemother; 1997 Dec; 41(12):2754-6. PubMed ID: 9420052
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Particular characteristics of the anti-human cytomegalovirus activity of (S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine (HPMPC) in vitro.
    Neyts J; Snoeck R; Balzarini J; De Clercq E
    Antiviral Res; 1991 Jul; 16(1):41-52. PubMed ID: 1663729
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of phosphonylmethoxyalkyl-purine and -pyrimidine derivatives on TK+ and TK- HSV-1 keratitis in rabbits.
    Maudgal PC; De Clercq E
    Antiviral Res; 1991 Jul; 16(1):93-100. PubMed ID: 1663731
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Successful treatment of progressive mucocutaneous infection due to acyclovir- and foscarnet-resistant herpes simplex virus with (S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine (HPMPC).
    Snoeck R; Andrei G; Gérard M; Silverman A; Hedderman A; Balzarini J; Sadzot-Delvaux C; Tricot G; Clumeck N; De Clercq E
    Clin Infect Dis; 1994 Apr; 18(4):570-8. PubMed ID: 8038312
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The clinical potential of the acyclic (and cyclic) nucleoside phosphonates: the magic of the phosphonate bond.
    De Clercq E
    Biochem Pharmacol; 2011 Jul; 82(2):99-109. PubMed ID: 21501598
    [TBL] [Abstract][Full Text] [Related]  

  • 26. New inhibitors of cytomegalovirus replication: in vitro evaluation, mechanism of action, and in vivo activity.
    Neyts J; De Clercq E
    Verh K Acad Geneeskd Belg; 1994; 56(6):561-92. PubMed ID: 7892749
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inhibitory effects of acyclic nucleoside phosphonate analogs, including (S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine, on Epstein-Barr virus replication.
    Lin JC; De Clercq E; Pagano JS
    Antimicrob Agents Chemother; 1991 Nov; 35(11):2440-3. PubMed ID: 1666500
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Efficacy of (S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine for the treatment of lethal vaccinia virus infections in severe combined immune deficiency (SCID) mice.
    Neyts J; De Clercq E
    J Med Virol; 1993 Nov; 41(3):242-6. PubMed ID: 8263505
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Broad-spectrum anti-DNA virus and anti-retrovirus activity of phosphonylmethoxyalkylpurines and -pyrimidines.
    De Clercq E
    Biochem Pharmacol; 1991 Aug; 42(5):963-72. PubMed ID: 1872902
    [No Abstract]   [Full Text] [Related]  

  • 30. DNA polymerase mutations in drug-resistant herpes simplex virus mutants determine in vivo neurovirulence and drug-enzyme interactions.
    Andrei G; Fiten P; Froeyen M; De Clercq E; Opdenakker G; Snoeck R
    Antivir Ther; 2007; 12(5):719-32. PubMed ID: 17713155
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluation of novel acyclic nucleoside phosphonates against human and animal gammaherpesviruses revealed an altered metabolism of cyclic prodrugs upon Epstein-Barr virus reactivation in P3HR-1 cells.
    Coen N; Duraffour S; Naesens L; Krecmerová M; Van den Oord J; Snoeck R; Andrei G
    J Virol; 2013 Nov; 87(22):12422-32. PubMed ID: 24027315
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antiviral activity of anti-cytomegalovirus agents (HPMPC, HPMPA) assessed by a flow cytometric method and DNA hybridization technique.
    Snoeck R; Schols D; Andrei G; Neyts J; De Clercq E
    Antiviral Res; 1991 Jul; 16(1):1-9. PubMed ID: 1663725
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Influence of intravitreal injections of HPMPC and related nucleoside analogues on intraocular pressure in guinea pig eyes.
    Banker AS; De Clercq E; Taskintuna I; Keefe KS; Bergeron-Lynn G; Freeman WR
    Invest Ophthalmol Vis Sci; 1998 Jun; 39(7):1233-42. PubMed ID: 9620084
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inhibitory effect of (S)-HPMPC, (S)-HPMPA, and 2'-nor-cyclic GMP on clinical ocular adenoviral isolates is serotype-dependent in vitro.
    Gordon YJ; Romanowski E; Araullo-Cruz T; Seaberg L; Erzurum S; Tolman R; De Clercq E
    Antiviral Res; 1991 Jul; 16(1):11-6. PubMed ID: 1776874
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A preclinical and clinical overview of the nucleotide-based antiviral agent cidofovir (HPMPC).
    Lalezari JP; Stagg RJ; Jaffe HS; Hitchcock MJ; Drew WL
    Adv Exp Med Biol; 1996; 394():105-15. PubMed ID: 8815677
    [No Abstract]   [Full Text] [Related]  

  • 36. The potential of acyclic nucleoside phosphonates as broad-spectrum antiviral agents.
    Naesens L; Balzarini J; De Clercq E
    Postepy Biochem; 1995; 41(5 Suppl):347-51. PubMed ID: 8797236
    [No Abstract]   [Full Text] [Related]  

  • 37. Selective inhibition of human cytomegalovirus DNA synthesis by (S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine [(S)-HPMPC] and 9-(1,3-dihydroxy-2-propoxymethyl)guanine (DHPG).
    Neyts J; Snoeck R; Schols D; Balzarini J; De Clercq E
    Virology; 1990 Nov; 179(1):41-50. PubMed ID: 2171213
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Acyclic adenine nucleoside phosphonates in plasma determined by high-performance liquid chromatography with fluorescence detection.
    Naesens L; Balzarini J; De Clercq E
    Clin Chem; 1992 Apr; 38(4):480-5. PubMed ID: 1568310
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inhibitory effects of potent inhibitors of human immunodeficiency virus and cytomegalovirus on the growth of human granulocyte-macrophage progenitor cells in vitro.
    Snoeck R; Lagneaux L; Delforge A; Bron D; Van der Auwera P; Stryckmans P; Balzarini J; De Clercq E
    Eur J Clin Microbiol Infect Dis; 1990 Aug; 9(8):615-9. PubMed ID: 2170136
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparative inhibitory effects of nucleoside analogues on different clinical isolates of human cytomegalovirus in vitro.
    Shigeta S; Konno K; Baba M; Yokota T; De Clercq E
    J Infect Dis; 1991 Feb; 163(2):270-5. PubMed ID: 1846389
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.